- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2010
- Public Summary Document (PSD) July 2010 PBAC Meeting - PDF
Imatinib – July 2010
IMATINIB, tablets, 100 mg and 400 mg (as mesylate), Glivec® Page last updated: 20 October 2010
Last updated
20 October 2010